Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations

Annals of Surgical Oncology

Volumn 18, Issue 8, 2011, Pages 2338-2347

  Kim, Young Ho ^a   Lee, Han Cheol ^b   Kim, Seon Young ^b   Yeom, Young Il ^b   Ryu, Kyung Ju ^a   Min, Byung Hoon ^a   Kim, Duk Hwan ^a   Son, Hee Jung ^a   Rhee, Poong Lyul ^a   Kim, Jae J ^a   Rhee, Jong Chul ^a   Kim, Hee Cheol ^a   Chun, Ho Kyung ^a   Grady, William M ^c   Kim, Yong Sung ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; DNA; MESSENGER RNA;

ADAMTS5 GENE; ADHFE1 GENE; ADULT; AGED; ARTICLE; BOLL GENE; CHROMOSOME 18; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; DOWN REGULATION; EPIGENETICS; EYA4 GENE; FEMALE; GAS7 GENE; GENE; GENE ABERRANT METHYLATION; GENE CLUSTER; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LAMA1 GENE; MAEL GENE; MALE; MICROARRAY ANALYSIS; NPY GENE; PROMOTER REGION; PYROSEQUENCING; RECTUM MUCOSA; SFT2D3 GENE; SLC6A15 GENE; TFPI2 GENE; TWIST1 GENE;

ADULT; AGED; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80051551226     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1573-y     Document Type: Article

References (55)

1. WM Grady JM Carethers 2008 Genomic and epigenetic instability in colorectal cancer pathogenesis Gastroenterology 135 1079 1099 18773902 10.1053/j.gastro.2008.07.076 1:CAS:528:DC%2BD1cXht12lur3K
2. Y Kondo JP Issa 2004 Epigenetic changes in colorectal cancer Cancer Metastasis Rev 23 29 39 15000147 10.1023/A:1025806911782 1:CAS:528: DC%2BD3sXnsFansr0%3D (Pubitemid 38221595)
3. YS Kim G Deng 2007 Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia Gut Liver 1 1 11 20485652 10.5009/gnl.2007.1.1.1 1:CAS:528:DC%2BD2sXhtFCgsrjJ
4. PW Laird 2003 The power and the promise of DNA methylation markers Nat Rev Cancer 3 253 266 12671664 10.1038/nrc1045 1:CAS:528:DC%2BD3sXisFajtL4%3D (Pubitemid 37328861)
5. DA Ahlquist HS Wieand CG Moertel, et al. 1993 Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests JAMA 269 1262 1267 8437303 10.1001/jama.269.10.1262 1:STN:280:DyaK3s7nt1Crsw%3D%3D (Pubitemid 23067429)
6. H Strul N Arber 2002 Fecal occult blood test for colorectal cancer screening Ann Oncol 13 51 56 11863111 10.1093/annonc/mdf076 1:STN:280: DC%2BD387islyltQ%3D%3D (Pubitemid 34436724)
7. JF Collins DA Lieberman TE Durbin DG Weiss 2005 Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice Ann Intern Med 142 81 85 15657155
8. TF Imperiale DF Ransohoff SH Itzkowitz BA Turnbull ME Ross 2004 Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population N Engl J Med 351 2704 2714 15616205 10.1056/NEJMoa033403 1:CAS:528:DC%2BD2MXhtFWisQ%3D%3D (Pubitemid 39665324)
9. KS Tagore TR Levin MJ Lawson 2004 The ecolution to stool DNA testing for colorectal cancer Aliment Pharmacol Ther 19 1225 1233 15191503 10.1111/j.1365-2036.2004.02005.x 1:CAS:528:DC%2BD2cXmsVSjtr4%3D (Pubitemid 38859498)
10. K Song AM Fendrick U Ladabaum 2004 Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis Gastroenterology 126 1270 1279 15131787 10.1053/j.gastro.2004.02.016 (Pubitemid 38552791)
11. J Smith-Ravin J England IC Talbot W Bodmer 1995 Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients Gut 36 81 86 7890240 10.1136/gut.36.1.81 1:CAS:528:DyaK2MXktFKmsLg%3D
12. L Luo WD Chen TP Pretlow 2005 CpG island methylation in aberrant crypt foci and cancers from the same patients Int J Cancer 115 747 751 15704093 10.1002/ijc.20936 1:CAS:528:DC%2BD2MXkvF2ks7k%3D (Pubitemid 40776698)
13. H Li L Myeroff D Smiraglia, et al. 2003 SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers Proc Natl Acad Sci USA 100 8412 8417 12829793 10.1073/pnas.1430846100 1:CAS:528:DC%2BD3sXlsFGntLg%3D (Pubitemid 36842559)
14. AO Chan RR Broaddus PS Houlihan JP Issa SR Hamilton A Rashid 2002 CpG island methylation in aberrant crypt foci of the colorectum Am J Pathol 160 1823 1830 12000733 10.1016/S0002-9440(10)61128-5 1:CAS:528:DC%2BD38XksVKrur0%3D (Pubitemid 34525661)
15. YH Kim Z Petko S Dzieciatkowski, et al. 2006 CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer Genes Chromosomes Cancer 45 781 789 16708352 10.1002/gcc.20341 1:CAS:528:DC%2BD28XmvVGrur8%3D
16. JM Cunningham ER Christensen DJ Tester, et al. 1998 Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability Cancer Res 58 3455 3460 9699680 1:CAS:528:DyaK1cXltFyis7Y%3D (Pubitemid 28371090)
17. JG Herman A Umar K Polyak, et al. 1998 Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma Proc Natl Acad Sci USA 95 6870 6875 9618505 10.1073/pnas.95.12.6870 1:CAS:528:DyaK1cXjslynu7s%3D (Pubitemid 28278073)
18. JM Wheeler NE Beck HC Kim IP Tomlinson NJ Mortensen WF Bodmer 1999 Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1 Proc Natl Acad Sci USA 96 10296 10301 10468602 10.1073/pnas.96.18.10296 1:CAS:528:DyaK1MXlvFensL8%3D (Pubitemid 29422552)
19. MF Kane M Loda GM Gaida, et al. 1997 Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines Cancer Res 57 808 811 9041175 1:CAS:528:DyaK2sXhs1Kjtbs%3D (Pubitemid 27097998)
20. ML Veigl L Kasturi J Olechnowicz, et al. 1998 Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers Proc Natl Acad Sci USA 95 8698 8702 9671741 10.1073/pnas.95.15.8698 1:CAS:528:DyaK1cXkvFalsL8%3D (Pubitemid 28350551)
21. H Suzuki DN Watkins KW Jair, et al. 2004 Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer Nat Genet 36 417 422 15034581 10.1038/ng1330 1:CAS:528:DC%2BD2cXis1ahtrY%3D (Pubitemid 38437267)
22. WD Chen ZJ Han J Skoletsky, et al. 2005 Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene J Natl Cancer Inst 97 1124 1132 16077070 10.1093/jnci/dji204 1:CAS:528:DC%2BD2MXpvVWis7c%3D (Pubitemid 41511211)
23. Z Petko M Ghiassi A Shuber, et al. 2005 Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps Clin Cancer Res 11 1203 1209 15709190 1:CAS:528:DC%2BD2MXht1yntLo%3D (Pubitemid 40175772)
24. WM Grady A Rajput JD Lutterbaugh SD Markowitz 2001 Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer Cancer Res 61 900 902 11221878 1:CAS:528:DC%2BD3MXhsFSrtbk%3D (Pubitemid 32174399)
25. P Adorjan J Distler E Lipscher, et al. 2002 Tumour class prediction and discovery by microarray-based DNA methylation analysis Nucleic Acids Res 30 e21 11861926 10.1093/nar/30.5.e21
26. JM Teodoridis J Hall S Marsh, et al. 2005 CpG island methylation of DNA damage response genes in advanced ovarian cancer Cancer Res 65 8961 8967 16204069 10.1158/0008-5472.CAN-05-1187 1:CAS:528:DC%2BD2MXhtVKiu7rN (Pubitemid 41377387)
27. M Toyota H Suzuki T Yamashita, et al. 2009 Cancer epigenomics: implications of DNA methylation in personalized cancer therapy Cancer Sci 100 787 791 19236379 10.1111/j.1349-7006.2009.01095.x 1:CAS:528:DC%2BD1MXls1SrtL0%3D
28. MF de Maat CJ van de Velde MP van der Werff, et al. 2008 Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence J Clin Oncol 26 2327 2335 18467724 10.1200/JCO.2007.14.0723
29. S Ogino K Nosho GJ Kirkner, et al. 2008 A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer J Natl Cancer Inst 100 1734 1738 19033568 10.1093/jnci/djn359 1:CAS:528:DC%2BD1cXhsVOgt7zM
30. EA Griffiths SD Gore 2008 DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes Semin Hematol 45 23 30 18179966 10.1053/j.seminhematol.2007.11.007 1:CAS:528:DC%2BD1cXhvFGhsrk%3D
31. J Lopez M Percharde HM Coley A Webb T Crook 2009 The context and potential of epigenetics in oncology Br J Cancer 100 571 577 19223907 10.1038/sj.bjc.6604930 1:CAS:528:DC%2BD1MXit1Oktb8%3D
32. M Bibikova Z Lin L Zhou, et al. 2006 High-throughput DNA methylation profiling using universal bead arrays Genome Res 16 383 393 16449502 10.1101/gr.4410706 1:CAS:528:DC%2BD28Xit1Kntrg%3D (Pubitemid 43327509)
33. M Bibikova E Chudin B Wu, et al. 2006 Human embryonic stem cells have a unique epigenetic signature Genome Res 16 1075 1083 16899657 10.1101/gr.5319906 1:CAS:528:DC%2BD28XpsFelsrw%3D (Pubitemid 44320394)
34. T Sjoblom S Jones LD Wood, et al. 2006 The consensus coding sequences of human breast and colorectal cancers Science 314 268 274 16959974 10.1126/science.1133427 (Pubitemid 44571966)
35. KE Schuebel W Chen L Cope, et al. 2007 Comparing the DNA hypermethylome with gene mutations in human colorectal cancer PLoS Genet 3 1709 1723 17892325 10.1371/journal.pgen.0030157 1:CAS:528:DC%2BD2sXhtFKmt77O (Pubitemid 47510263)
36. MR Estécio PS Yan AE Ibrahim, et al. 2007 High-throughput methylation profiling by MCA coupled to CpG island microarray Genome Res 17 1529 1536 17785535 10.1101/gr.6417007 (Pubitemid 47529437)
37. Y Mori K Cai Y Cheng, et al. 2006 A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer Gastroenterology 131 797 808 16952549 10.1053/j.gastro.2006.06.006 1:CAS:528:DC%2BD28XhtVKrurnM (Pubitemid 44307065)
38. M Weber JJ Davies D Wittig, et al. 2005 Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells Nat Genet 37 853 862 16007088 10.1038/ng1598 1:CAS:528:DC%2BD2MXmsFKmu7o%3D (Pubitemid 41077111)
39. CC Maley PC Galipeau X Li CA Sanchez TG Paulson BJ Reid 2004 Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus Cancer Res 64 3414 3427 15150093 10.1158/0008-5472.CAN-03- 3249 1:CAS:528:DC%2BD2cXktVWhs7k%3D (Pubitemid 38657913)
40. EH Lips R van Eijk EJ de Graaf, et al. 2008 Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis BMC Cancer 8 314 18959792 10.1186/1471-2407-8-314
41. J Cardoso J Boer H Morreau R Fodde 2007 Expression and genomic profiling of colorectal cancer Biochim Biophys Acta 1775 103 137 17010523 1:CAS:528:DC%2BD28Xhtlaltr7J (Pubitemid 44881195)
42. WM Grady 2005 Epigenetic events in the colorectum and in colon cancer Biochem Soc Trans 33 684 688 16042574 10.1042/BST0330684 1:CAS:528: DC%2BD2MXmvFSnu7s%3D (Pubitemid 41160839)
43. SC Glockner M Dhir JM Yi, et al. 2009 Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer Cancer Res 69 4691 4699 19435926 10.1158/0008-5472.CAN-08-0142 1:CAS:528:DC%2BD1MXmsFGlurw%3D
44. S Tsunoda E Smith NJ De Young, et al. 2009 Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma Oncol Rep 21 1067 1073 19288010 10.3892/or-00000325 1:CAS:528:DC%2BD1MXksVSrtLc%3D
45. A Tanemura AM Terando MS Sim, et al. 2009 CpG island methylator phenotype predicts progression of malignant melanoma Clin Cancer Res 15 1801 1807 19223509 10.1158/1078-0432.CCR-08-1361 1:CAS:528:DC%2BD1MXisVWrsL0%3D
46. CD Jee MA Kim EJ Jung J Kim WH Kim 2009 Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma Eur J Cancer 45 1282 1293 19195878 10.1016/j.ejca.2008.12.027 1:CAS:528: DC%2BD1MXktlyqtLw%3D
47. MA Parsi A Li CP Li M Goggins 2008 DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease Clin Gastroenterol Hepatol 6 1270 1278 18995218 10.1016/j.cgh.2008.07.007 1:CAS:528:DC%2BD1MXms1er
48. SM Hong D Kelly M Griffith, et al. 2008 Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas Mod Pathol 21 1499 1507 18820670 10.1038/modpathol.2008.157 1:CAS:528: DC%2BD1cXhsVSjsb3P
49. S Liu S Ren P Howell O Fodstad AI Riker 2008 Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling Pigment Cell Melanoma Res 21 545 558 18627528 10.1111/j.1755-148X. 2008.00484.x 1:CAS:528:DC%2BD1cXht1Kqt73M
50. P Sova Q Feng G Geiss, et al. 2006 Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis Cancer Epidemiol Biomarkers Prev 15 114 123 16434596 10.1158/1055-9965.EPI-05- 0323 1:CAS:528:DC%2BD28XmvVSgtw%3D%3D
51. TL Tootle SJ Silver EL Davies, et al. 2003 The transcription factor Eyes absent is a protein tyrosine phosphatase Nature 426 299 302 14628053 10.1038/nature02097 1:CAS:528:DC%2BD3sXptVOitrw%3D (Pubitemid 37463149)
52. H Zou NK Osborn JJ Harrington, et al. 2005 Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma Cancer Epidemiol Biomarkers Prev 14 830 834 15824152 10.1158/1055-9965.EPI-04-0506 1:CAS:528:DC%2BD2MXjtFSkur8%3D (Pubitemid 40478544)
53. NK Osborn H Zou JR Molina, et al. 2006 Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia Clin Gastroenterol Hepatol 4 212 218 16469682 10.1016/j.cgh.2005.11.009 1:CAS:528: DC%2BD28Xit1Kjsr8%3D (Pubitemid 43199692)
54. EH Gort KP Suijkerbuijk SM Roothaan, et al. 2008 Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer Cancer Epidemiol Biomarkers Prev 17 3325 3330 19064546 10.1158/1055-9965.EPI-08-0472 1:CAS:528:DC%2BD1cXhsVOgtLzI
55. M Ogasawara J Murata K Ayukawa I Saiki 1997 Differential effect of intestinal neuropeptides on invasion and migration of colon carcinoma cells in vitro Cancer Lett 119 125 130 18372531 10.1016/S0304-3835(97)81762-4 1:CAS:528:DyaK2sXmslWksrw%3D